Brighter (BRIG.ST) Stock Analysis & AI Equity Report
Brighter (BRIG.ST) overview
Brighter (BRIG.ST) stock analysis and AI equity research. For the latest completed financial year, 2021, Brighter reported revenue of SEK 1.3m and operating profit of SEK -205m; the year-end share price was N/A and market capitalisation was N/A. Brighter is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Brighter's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-05. Data will be refreshed during report generation.
About Brighter
Brighter AB is a Swedish health-tech company that develops daily-care solutions for people living with chronic diseases. Its products are designed to collect and share real-life treatment data between patients, relatives and care providers, supporting more informed care and research. The company is certified under ISO 13485 and listed on Nasdaq First North Growth Market.
Generate the Brighter report
Brighter is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Brighter and represent the latest completed financial year (2021). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.